COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:CRI - FR0000130692 - Common Stock
10.4 EUR
-0.02 (-0.19%)
We assign a fundamental rating of 3 out of 10 to CRI. CRI was compared to 15 industry peers in the Industrial Conglomerates industry. CRI may be in some trouble as it scores bad on both profitability and health. CRI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
CRI had positive earnings in the past year.
In the past year CRI had a positive cash flow from operations.
Of the past 5 years CRI 4 years were profitable.
In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
CRI's Return On Assets of 0.28% is on the low side compared to the rest of the industry. CRI is outperformed by 68.75% of its industry peers.
With a Return On Equity value of 1.03%, CRI is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
CRI's Return On Invested Capital of 5.14% is fine compared to the rest of the industry. CRI outperforms 62.50% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRI is in line with the industry average of 6.40%.
The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.14%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROIC | 5.14% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
CRI's Profit Margin of 0.37% is on the low side compared to the rest of the industry. CRI is outperformed by 68.75% of its industry peers.
In the last couple of years the Profit Margin of CRI has declined.
The Operating Margin of CRI (6.41%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CRI has remained more or less at the same level.
The Gross Margin of CRI (28.51%) is worse than 81.25% of its industry peers.
In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.41% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
CRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CRI has been increased compared to 1 year ago.
Compared to 5 years ago, CRI has more shares outstanding
CRI has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.24, we must say that CRI is in the distress zone and has some risk of bankruptcy.
CRI has a Altman-Z score of 1.24. This is amonst the worse of the industry: CRI underperforms 81.25% of its industry peers.
The Debt to FCF ratio of CRI is 124.09, which is on the high side as it means it would take CRI, 124.09 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 124.09, CRI is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
CRI has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CRI (1.38) is worse than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 124.09 | ||
| Altman-Z | 1.24 |
ROIC/WACC0.85
WACC6.08%
2.3 Liquidity
CRI has a Current Ratio of 1.30. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
CRI has a worse Current ratio (1.30) than 87.50% of its industry peers.
CRI has a Quick Ratio of 1.30. This is a bad value and indicates that CRI is not financially healthy enough and could expect problems in meeting its short term obligations.
CRI has a Quick ratio of 0.86. This is in the lower half of the industry: CRI underperforms 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 150.24% over the past year.
Measured over the past years, CRI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.59% on average per year.
Looking at the last year, CRI shows a small growth in Revenue. The Revenue has grown by 6.67% in the last year.
The Revenue has been growing slightly by 3.10% on average over the past years.
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 32.19% on average per year.
The Revenue is expected to grow by 3.45% on average over the next years.
EPS Next Y7.79%
EPS Next 2Y41.87%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 80.00, CRI can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CRI indicates a slightly more expensive valuation: CRI is more expensive than 68.75% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CRI to the average of the S&P500 Index (27.19), we can say CRI is valued expensively.
The Price/Forward Earnings ratio is 11.70, which indicates a very decent valuation of CRI.
Based on the Price/Forward Earnings ratio, CRI is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.92. CRI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80 | ||
| Fwd PE | 11.7 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRI indicates a somewhat cheap valuation: CRI is cheaper than 75.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CRI is valued a bit more expensive than 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 76.13 | ||
| EV/EBITDA | 7.4 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CRI's earnings are expected to grow with 32.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)10.26
PEG (5Y)N/A
EPS Next 2Y41.87%
EPS Next 3Y32.19%
5. Dividend
5.1 Amount
CRI has a Yearly Dividend Yield of 1.25%.
CRI's Dividend Yield is slightly below the industry average, which is at 3.19.
Compared to the average S&P500 Dividend Yield of 1.92, CRI is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.25% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
118.52% of the earnings are spent on dividend by CRI. This is not a sustainable payout ratio.
DP118.52%
EPS Next 2Y41.87%
EPS Next 3Y32.19%
EPA:CRI (1/9/2026, 7:00:00 PM)
10.4
-0.02 (-0.19%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners4.68%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap258.86M
Revenue(TTM)727.50M
Net Income(TTM)2.70M
Analysts74.29
Price Target11.56 (11.15%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.25% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP118.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-26.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80 | ||
| Fwd PE | 11.7 | ||
| P/S | 0.36 | ||
| P/FCF | 76.13 | ||
| P/OCF | 10.88 | ||
| P/B | 0.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.4 |
EPS(TTM)0.13
EY1.25%
EPS(NY)0.89
Fwd EY8.55%
FCF(TTM)0.14
FCFY1.31%
OCF(TTM)0.96
OCFY9.19%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)10.26
PEG (5Y)N/A
Graham Number5.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROCE | 7.02% | ||
| ROIC | 5.14% | ||
| ROICexc | 6.13% | ||
| ROICexgc | 13.12% | ||
| OM | 6.41% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% | ||
| FCFM | 0.47% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexgc growth 3Y-6.3%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 124.09 | ||
| Debt/EBITDA | 4.67 | ||
| Cap/Depr | 66.89% | ||
| Cap/Sales | 2.8% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.87% | ||
| Profit Quality | 125.93% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 1.24 |
F-Score7
WACC6.08%
ROIC/WACC0.85
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y7.79%
EPS Next 2Y41.87%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
EBIT growth 1Y57.43%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year104.23%
EBIT Next 3Y38.23%
EBIT Next 5YN/A
FCF growth 1Y109.66%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y244.24%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%
COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ
What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.
What is the valuation status of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a valuation rating of 4 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Fairly Valued.
What is the profitability of CRI stock?
COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for CRI stock?
The Price/Earnings (PE) ratio for COMPAGNIE CHARGEURS INVEST (CRI.PA) is 80 and the Price/Book (PB) ratio is 0.99.
How financially healthy is COMPAGNIE CHARGEURS INVEST?
The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.